The GLP-1 market is a massive opportunity in healthcare, and many companies are vying for a piece of it. Healthcare companies have been feverishly working on developing GLP-1 weight loss products in ...

GLP-1 receptor agonists may confer neuroprotection via reduced neuroinflammation, inhibited apoptosis, and vasodilatory effects that enhance cerebral perfusion through cAMP and VEGF-related pathways.

The cost of GLP-1 medications varies widely, ranging from around $199 to over $1,500. Insurance coverage for GLP-1s is more common for diabetes management than for weight loss. Consumers can ...

Forbes contributors publish independent expert analyses and insights. Julian Hayes II combines wellness, business, and leadership. This voice experience is generated by AI. Learn more. This voice ...

Relations among brand-name GLP-1 manufacturers and compounding pharmacies are deteriorating as weight loss pills enter the U.S. market and competition intensifies. Hims & Hers is selling the ...

During February’s national Heart Health Awareness Month, it’s important to note that GLP-1 drugs like Ozempic and Wegovy are surging at historic levels. Nearly 12% of U.S. adults now report using a ...

Researchers at Steno Diabetes Center Copenhagen reported that starting a GLP-1 receptor agonist (GLP-1RA) coincided with slightly healthier supermarket purchases. Grocery purchases from GLP-1RA users ...

Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage ...

GLP-1 drugs have gained worldwide attention for their ability to help some people lose weight, and new research shows they may be able to help with another common problem: Alcohol use. Patients who ...

View post: Winter Storm Warning in 3 States for 2 Feet of Snow and 70 MPH Winds Called Worst in 10 Years GLP-3s are investigational, potent weight-loss drugs targeting multiple hormone receptors. Side ...

GLP-1 drugs have dominated the food and beverage conversation for the past two years. They’ve reignited an industry-wide fixation on weight loss as body positivity wanes, driven waves of new product ...

People say GLP-1 drugs caused them to relapse on long-dormant eating disorders. NY Post/Don Pearsall Welcome to The Thin Line, The New York Post’s new series about the darker side of GLP-1 drugs.